Keywords: Germany, Pharma research, Heart disease, Rheumatism, VFA

German pharma hails progress against heart disease and rheumatism

Article | 13 October 2011

Cardiovascular disease is the most common cause of death in Germany, with 60,000 people dying of a heart attack every year. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in